Catalina West, | |
304 W Hay St Ste 212, Decatur, IL 62526-6376 | |
(217) 876-4390 | |
(217) 876-4395 |
Full Name | Catalina West |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 304 W Hay St Ste 212, Decatur, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659071868 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 209026829 (Illinois) | Secondary |
363LF0000X | Nurse Practitioner - Family | 209026829 (Illinois) | Primary |
Entity Name | Decatur Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164477725 PECOS PAC ID: 6204731144 Enrollment ID: O20031203000685 |
News Archive
An experimental vaccine developed by researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute targets overactive antigens in highly aggressive brain tumors and improves length of survival in newly diagnosed patients, according to new data that was presented in a poster session at the 47th Annual Meeting of the American Society of Clinical Oncology.
Studies have shown positron emission tomography's (PET) value as a minimally invasive, painless and safe diagnostic tool for many pediatric conditions. In a study published in the February issue of The Journal of Nuclear Medicine (JNM), researchers at the Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania (Penn) gathered data that may provide clinicians with new formulas-specific to pediatrics-to calculate the amount of radiotracer that should be injected based on the patient's weight.
A new study led by researchers at UC San Francisco and Kaiser Permanente has identified genetic predictors of normal prostate-specific antigen (PSA) levels in healthy men, which could be used to improve the accuracy of PSA-based prostate cancer screening tests.
Using a short piece of DNA as a template, a team of investigators at North Carolina State University has assembled a complete viral coat around a gold nanoparticle.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Catalina West, 1674 Seven Pines Rd Apt 202, Springfield, IL 62704-5741 Ph: (217) 671-3666 | Catalina West, 304 W Hay St Ste 212, Decatur, IL 62526-6376 Ph: (217) 876-4390 |
News Archive
An experimental vaccine developed by researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute targets overactive antigens in highly aggressive brain tumors and improves length of survival in newly diagnosed patients, according to new data that was presented in a poster session at the 47th Annual Meeting of the American Society of Clinical Oncology.
Studies have shown positron emission tomography's (PET) value as a minimally invasive, painless and safe diagnostic tool for many pediatric conditions. In a study published in the February issue of The Journal of Nuclear Medicine (JNM), researchers at the Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania (Penn) gathered data that may provide clinicians with new formulas-specific to pediatrics-to calculate the amount of radiotracer that should be injected based on the patient's weight.
A new study led by researchers at UC San Francisco and Kaiser Permanente has identified genetic predictors of normal prostate-specific antigen (PSA) levels in healthy men, which could be used to improve the accuracy of PSA-based prostate cancer screening tests.
Using a short piece of DNA as a template, a team of investigators at North Carolina State University has assembled a complete viral coat around a gold nanoparticle.
› Verified 4 days ago